AKT1 and ischemia: Moreover, our results show now that TLR4 blockade with TAK-246 greatly reduces cell viability and phosphorylation of Akt and ERK1/2 during the treatments of simulated ischemia only and sI/R only, suggesting that TLR4 activation exerts a protective role in CFs during these adverse conditions.